Evgeny Kiselev1, Thomas S Dexheimer, Yves Pommier, Mark Cushman. 1. Department of Medicinal Chemistry and Molecular Pharmacology, School of Pharmacy, and The Purdue Center for Cancer Research, Purdue University, West Lafayette, Indiana 47907, USA.
Abstract
Indenoisoquinoline topoisomerase I (Top1) inhibitors are a novel class of anticancer agents. Modifications of the indenoisoquinoline A, B, and D rings have been extensively studied in order to optimize Top1 inhibitory activity and cytotoxicity. To improve understanding of the forces that stabilize drug-Top1-DNA ternary complexes, the five-membered cyclopentadienone C-ring of the indenoisoquinoline system was replaced by six-membered nitrogen heterocyclic rings, resulting in dibenzo[c,h][1,6]naphthyridines that were synthesized by a novel route and tested for Top1 inhibition. This resulted in several compounds that have unique DNA cleavage site selectivities and potent antitumor activities in a number of cancer cell lines.
Indenoisoquinoline topoisomerase I (Top1) inhibitors are a novel class of antin class="Disease">cancer agents. Modifications of the indenoisoquinoline A, B, and D rings have been extensively studied in order to optimize Top1 inhibitory activity and cytotoxicity. To improve understanding of the forces that stabilize drug-Top1-DNA ternary complexes, the five-membered cyclopentadienone C-ring of the indenoisoquinoline system was replaced by six-membered nitrogen heterocyclic rings, resulting in dibenzo[c,h][1,6]naphthyridines that were synthesized by a novel route and tested for Top1 inhibition. This resulted in several compounds that have unique DNA cleavage site selectivities and potent antitumor activities in a number of cancer cell lines.
Authors: M Cushman; M Jayaraman; J A Vroman; A K Fukunaga; B M Fox; G Kohlhagen; D Strumberg; Y Pommier Journal: J Med Chem Date: 2000-10-05 Impact factor: 7.446
Authors: P Skehan; R Storeng; D Scudiero; A Monks; J McMahon; D Vistica; J T Warren; H Bokesch; S Kenney; M R Boyd Journal: J Natl Cancer Inst Date: 1990-07-04 Impact factor: 13.506
Authors: Tsai-Kun Li; Peter J Houghton; Shyamal D Desai; Parima Daroui; Angela A Liu; Eszter S Hars; Alexander L Ruchelman; Edmond J LaVoie; Leroy F Liu Journal: Cancer Res Date: 2003-12-01 Impact factor: 12.701
Authors: Peng-Cheng Lv; Mohamed S A Elsayed; Keli Agama; Christophe Marchand; Yves Pommier; Mark Cushman Journal: J Med Chem Date: 2016-04-20 Impact factor: 7.446
Authors: Yi Zhi; Jin Yang; Shengchao Tian; Fang Yuan; Yang Liu; Yi Zhang; Pinghua Sun; Bo Song; Zhiwen Chen Journal: Int J Mol Sci Date: 2012-05-18 Impact factor: 6.208